Variable manifestation in natural killer cell leukaemia

Summary Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and laboratory haematology 2003-08, Vol.25 (4), p.239-245
Hauptverfasser: Kuroda, J., Kimura, S., Kobayashi, Y., Jyoko, N., Kamitsuji, Y., Murotani, Y., Fukuda, W., Akaogi, T., Hayashi, H., Yoshikawa, T., Maekawa, T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 245
container_issue 4
container_start_page 239
container_title Clinical and laboratory haematology
container_volume 25
creator Kuroda, J.
Kimura, S.
Kobayashi, Y.
Jyoko, N.
Kamitsuji, Y.
Murotani, Y.
Fukuda, W.
Akaogi, T.
Hayashi, H.
Yoshikawa, T.
Maekawa, T.
description Summary Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.
doi_str_mv 10.1046/j.1365-2257.2003.00528.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73522277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73522277</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3868-17e9c24d4677d6ea460e38c5076e8957887c37766fab769acd9440f2a505ee003</originalsourceid><addsrcrecordid>eNpFkE1P20AQhlcIVFLoX0C-wM3ufs_6wKEKLQFFrZD4OK4mzljaZO1Qb6yGf1-7SeE0I83zjmYexjLBC8G1_boqhLIml9JAITlXBedGumJ3xCbvg2M24UKLvHRGn7LPKa04F0oAfGKnQrqSC6smDJ6xC7iIlDXYhprSFrdh02ahzVrc9h3GbB1ipC6rKMYsUr9GagKes5MaY6Ivh3rGnn58f5zO8vmv27vpt3leKWddLoDKSuqltgBLS6gtJ-Uqw8GSKw04B5UCsLbGBdgSq2WpNa8lGm6Ihs_O2NV-72u3-d0P5_kmpPEUbGnTJw_KSCkBBvDiAPaLhpb-tQsNdm_-_6sDcHkAMFUY6w7bKqQPznCuS-MG7nrP_QmR3j7m3I_q_cqPhv1o2I_q_T_1fufv7uezoRvy-T4f0pZ273ns1t6CAuNfft762YO5mapn4x_VX_1ThBo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73522277</pqid></control><display><type>article</type><title>Variable manifestation in natural killer cell leukaemia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kuroda, J. ; Kimura, S. ; Kobayashi, Y. ; Jyoko, N. ; Kamitsuji, Y. ; Murotani, Y. ; Fukuda, W. ; Akaogi, T. ; Hayashi, H. ; Yoshikawa, T. ; Maekawa, T.</creator><creatorcontrib>Kuroda, J. ; Kimura, S. ; Kobayashi, Y. ; Jyoko, N. ; Kamitsuji, Y. ; Murotani, Y. ; Fukuda, W. ; Akaogi, T. ; Hayashi, H. ; Yoshikawa, T. ; Maekawa, T.</creatorcontrib><description>Summary Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.</description><identifier>ISSN: 0141-9854</identifier><identifier>EISSN: 1365-2257</identifier><identifier>DOI: 10.1046/j.1365-2257.2003.00528.x</identifier><identifier>PMID: 12890163</identifier><identifier>CODEN: CLHAD3</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adult ; Aged ; Antigens, CD - analysis ; Antigens, Neoplasm - analysis ; Biological and medical sciences ; Bone marrow transplantation ; CD4 ; Chromosome Aberrations ; Chromosome Banding ; Hematologic and hematopoietic diseases ; Humans ; hypogranular variant ; Immunophenotyping ; Karyotyping ; Killer Cells, Natural - chemistry ; Killer Cells, Natural - pathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; natural killer cell leukaemia ; Neoplastic Stem Cells - chemistry ; Neoplastic Stem Cells - pathology ; Peroxidase - analysis ; Phenotype ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology ; Prognosis ; spectral karyotyping</subject><ispartof>Clinical and laboratory haematology, 2003-08, Vol.25 (4), p.239-245</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3868-17e9c24d4677d6ea460e38c5076e8957887c37766fab769acd9440f2a505ee003</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2257.2003.00528.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2257.2003.00528.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15004958$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12890163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuroda, J.</creatorcontrib><creatorcontrib>Kimura, S.</creatorcontrib><creatorcontrib>Kobayashi, Y.</creatorcontrib><creatorcontrib>Jyoko, N.</creatorcontrib><creatorcontrib>Kamitsuji, Y.</creatorcontrib><creatorcontrib>Murotani, Y.</creatorcontrib><creatorcontrib>Fukuda, W.</creatorcontrib><creatorcontrib>Akaogi, T.</creatorcontrib><creatorcontrib>Hayashi, H.</creatorcontrib><creatorcontrib>Yoshikawa, T.</creatorcontrib><creatorcontrib>Maekawa, T.</creatorcontrib><title>Variable manifestation in natural killer cell leukaemia</title><title>Clinical and laboratory haematology</title><addtitle>Clin Lab Haematol</addtitle><description>Summary Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigens, CD - analysis</subject><subject>Antigens, Neoplasm - analysis</subject><subject>Biological and medical sciences</subject><subject>Bone marrow transplantation</subject><subject>CD4</subject><subject>Chromosome Aberrations</subject><subject>Chromosome Banding</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>hypogranular variant</subject><subject>Immunophenotyping</subject><subject>Karyotyping</subject><subject>Killer Cells, Natural - chemistry</subject><subject>Killer Cells, Natural - pathology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>natural killer cell leukaemia</subject><subject>Neoplastic Stem Cells - chemistry</subject><subject>Neoplastic Stem Cells - pathology</subject><subject>Peroxidase - analysis</subject><subject>Phenotype</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology</subject><subject>Prognosis</subject><subject>spectral karyotyping</subject><issn>0141-9854</issn><issn>1365-2257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1P20AQhlcIVFLoX0C-wM3ufs_6wKEKLQFFrZD4OK4mzljaZO1Qb6yGf1-7SeE0I83zjmYexjLBC8G1_boqhLIml9JAITlXBedGumJ3xCbvg2M24UKLvHRGn7LPKa04F0oAfGKnQrqSC6smDJ6xC7iIlDXYhprSFrdh02ahzVrc9h3GbB1ipC6rKMYsUr9GagKes5MaY6Ivh3rGnn58f5zO8vmv27vpt3leKWddLoDKSuqltgBLS6gtJ-Uqw8GSKw04B5UCsLbGBdgSq2WpNa8lGm6Ihs_O2NV-72u3-d0P5_kmpPEUbGnTJw_KSCkBBvDiAPaLhpb-tQsNdm_-_6sDcHkAMFUY6w7bKqQPznCuS-MG7nrP_QmR3j7m3I_q_cqPhv1o2I_q_T_1fufv7uezoRvy-T4f0pZ273ns1t6CAuNfft762YO5mapn4x_VX_1ThBo</recordid><startdate>200308</startdate><enddate>200308</enddate><creator>Kuroda, J.</creator><creator>Kimura, S.</creator><creator>Kobayashi, Y.</creator><creator>Jyoko, N.</creator><creator>Kamitsuji, Y.</creator><creator>Murotani, Y.</creator><creator>Fukuda, W.</creator><creator>Akaogi, T.</creator><creator>Hayashi, H.</creator><creator>Yoshikawa, T.</creator><creator>Maekawa, T.</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200308</creationdate><title>Variable manifestation in natural killer cell leukaemia</title><author>Kuroda, J. ; Kimura, S. ; Kobayashi, Y. ; Jyoko, N. ; Kamitsuji, Y. ; Murotani, Y. ; Fukuda, W. ; Akaogi, T. ; Hayashi, H. ; Yoshikawa, T. ; Maekawa, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3868-17e9c24d4677d6ea460e38c5076e8957887c37766fab769acd9440f2a505ee003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigens, CD - analysis</topic><topic>Antigens, Neoplasm - analysis</topic><topic>Biological and medical sciences</topic><topic>Bone marrow transplantation</topic><topic>CD4</topic><topic>Chromosome Aberrations</topic><topic>Chromosome Banding</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>hypogranular variant</topic><topic>Immunophenotyping</topic><topic>Karyotyping</topic><topic>Killer Cells, Natural - chemistry</topic><topic>Killer Cells, Natural - pathology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>natural killer cell leukaemia</topic><topic>Neoplastic Stem Cells - chemistry</topic><topic>Neoplastic Stem Cells - pathology</topic><topic>Peroxidase - analysis</topic><topic>Phenotype</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology</topic><topic>Prognosis</topic><topic>spectral karyotyping</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuroda, J.</creatorcontrib><creatorcontrib>Kimura, S.</creatorcontrib><creatorcontrib>Kobayashi, Y.</creatorcontrib><creatorcontrib>Jyoko, N.</creatorcontrib><creatorcontrib>Kamitsuji, Y.</creatorcontrib><creatorcontrib>Murotani, Y.</creatorcontrib><creatorcontrib>Fukuda, W.</creatorcontrib><creatorcontrib>Akaogi, T.</creatorcontrib><creatorcontrib>Hayashi, H.</creatorcontrib><creatorcontrib>Yoshikawa, T.</creatorcontrib><creatorcontrib>Maekawa, T.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and laboratory haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuroda, J.</au><au>Kimura, S.</au><au>Kobayashi, Y.</au><au>Jyoko, N.</au><au>Kamitsuji, Y.</au><au>Murotani, Y.</au><au>Fukuda, W.</au><au>Akaogi, T.</au><au>Hayashi, H.</au><au>Yoshikawa, T.</au><au>Maekawa, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variable manifestation in natural killer cell leukaemia</atitle><jtitle>Clinical and laboratory haematology</jtitle><addtitle>Clin Lab Haematol</addtitle><date>2003-08</date><risdate>2003</risdate><volume>25</volume><issue>4</issue><spage>239</spage><epage>245</epage><pages>239-245</pages><issn>0141-9854</issn><eissn>1365-2257</eissn><coden>CLHAD3</coden><abstract>Summary Natural killer (NK) cell leukaemias are a relatively rare group of haematological disorders, now entitled in the T/NK lymphoproliferative disorders in the new WHO classification. Recent studies have clarified their biological and clinical manifestation gradually. However, some cases with NK malignancies still remain difficult to diagnose and differentiate into their subtypes in the absence of a distinct diagnostic hallmark, especially at initial presentation. We describe herein five patients with NK leukaemias with respect to the clinical, cytological, immunological and cytogenetic characteristics, varied among each case. Cytologically, two aggressive NK cell leukaemia/lymphoma (ANKL/L) cases were a morphologically hypogranular variant form. Clinically, one with ANKL/L was presented as haemophagocytic syndrome without leukaemic infiltration. Systemic chemotherapy resulted in complete remission in one ANKL/L and two blastic NK cell leukaemia/lymphoma (BNKL/L) patients; however, a good long‐term outcome was achieved in only one CD4‐positive BNKL/L patient with allogenic bone marrow transplantation. Cytogenetic analysis revealed that recurrent chromosomal aberration was rare; however, two had aberrations at 10p11 and 11q13. From these findings, we conclude that comprehensive individual studies should be carried out in these patients to obtain a correct diagnosis and to design an optimal therapeutic approach.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>12890163</pmid><doi>10.1046/j.1365-2257.2003.00528.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0141-9854
ispartof Clinical and laboratory haematology, 2003-08, Vol.25 (4), p.239-245
issn 0141-9854
1365-2257
language eng
recordid cdi_proquest_miscellaneous_73522277
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Antigens, CD - analysis
Antigens, Neoplasm - analysis
Biological and medical sciences
Bone marrow transplantation
CD4
Chromosome Aberrations
Chromosome Banding
Hematologic and hematopoietic diseases
Humans
hypogranular variant
Immunophenotyping
Karyotyping
Killer Cells, Natural - chemistry
Killer Cells, Natural - pathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical sciences
Middle Aged
natural killer cell leukaemia
Neoplastic Stem Cells - chemistry
Neoplastic Stem Cells - pathology
Peroxidase - analysis
Phenotype
Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Prognosis
spectral karyotyping
title Variable manifestation in natural killer cell leukaemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T21%3A32%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variable%20manifestation%20in%20natural%20killer%20cell%20leukaemia&rft.jtitle=Clinical%20and%20laboratory%20haematology&rft.au=Kuroda,%20J.&rft.date=2003-08&rft.volume=25&rft.issue=4&rft.spage=239&rft.epage=245&rft.pages=239-245&rft.issn=0141-9854&rft.eissn=1365-2257&rft.coden=CLHAD3&rft_id=info:doi/10.1046/j.1365-2257.2003.00528.x&rft_dat=%3Cproquest_pubme%3E73522277%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73522277&rft_id=info:pmid/12890163&rfr_iscdi=true